Renegade Economists Show 589
As broadcast on the 3CR airwaves 6 – 6.30pm on the fourth Wednesday of the month.
Subscribe to the monthly podcast.
Show Notes
Has Big Pharma exposed society to undue risk in the covid era? In our 2nd episode on this issue, Tahir Amin (i-mak.org) takes us through the R & D ecosystem of pharmaceutical development. Is Big Pharma’s role to develop life saving products or digest competition? Listeners will understand why this market is in urgent need of a major overhaul. As always, policy pathways are provided as a matter of courtesy.
Related Links
Tahir Amin & Rohit Malpani – Covid-19 has exposed the limits of the pharmaceutical model.
Big Pharma, Little Science? A bibliometric perspective on Big Pharma’s R&D decline.
The never-ending drip of pharmaceutical patents.
With no prospects for profits, Big Pharma neglects new infectious diseases.
Pharma can only think 18 months ahead.
Now is the time for Open Access Science
Check the previous podcourse shows, designed for those wanting to understand the basics of Georgism.
Review the past 573 weekly shows
Georgist Glossary
Follow the Twitter and watch #LVT, #commons, #rentier.
Share with your friends, or if you could, provide an itunes review for the show. Thankyou!
Photo by National Cancer Institute on Unsplash
